Pharmacokinetics and the optimal regimen for levofloxacin in critically ill patients receiving continuous hemodiafiltration

The aim of this study was to establish the pharmacokinetics of levofloxacin (LVFX) and determine the optimal dose of this drug in critically ill patients receiving continuous hemodiafiltration (CHDF). The results of in vivo and in vitro studies showed the pharmacokinetics of LVFX total clearance (CL...

Descripción completa

Detalles Bibliográficos
Autores principales: Wada, Takeshi, Kobayashi, Masaki, Ono, Yuichi, Mizugaki, Asumi, Katabami, Kenichi, Maekawa, Kunihiko, Miyamoto, Daisuke, Yanagida, Yuichiro, Hayakawa, Mineji, Sawamura, Atsushi, Iseki, Ken, Gando, Satoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4436099/
https://www.ncbi.nlm.nih.gov/pubmed/25992293
http://dx.doi.org/10.1186/s40560-015-0089-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4436099/
https://www.ncbi.nlm.nih.gov/pubmed/25992293
http://dx.doi.org/10.1186/s40560-015-0089-0

Ejemplares similares